Latest Articles

  • Is there a role for chronic suppressive therapy in herpes simplex virus infection?
    Sandhya R. Nagarakanti, MD, FIDSA and Ahmed M. Zikri, PharmD
    Cleveland Clinic Journal of Medicine March 2024, 91 (3) 151-153; DOI: https://doi.org/10.3949/ccjm.91a.23099

    Yes, in patients with recurrent oral and genital HSV-2 infection and oral HSV-1 infection.

  • Does my patient have testosterone deficiency?
    Andrew D. Shumaker, MD, Navid Leelani, DO, Bradley Roth, Prajit Khooblall, MD, Raevti Bole, MD, Scott D. Lundy, MD, PhD and Petar Bajic, MD
    Cleveland Clinic Journal of Medicine February 2024, 91 (2) 93-95; DOI: https://doi.org/10.3949/ccjm.91a.23064

    Diagnosis of testosterone deficiency requires the presence of relevant signs or symptoms along with biochemical evidence.

  • Dealing with the “T” (testosterone)
    Brian F. Mandell, MD, PhD
    Cleveland Clinic Journal of Medicine February 2024, 91 (2) 78-79; DOI: https://doi.org/10.3949/ccjm.91b.02024

    If a patient feels better when taking testosterone supplementation, is it the “T” or is it a placebo effect?

  • What are the management considerations for venous thromboembolic events in patients with cirrhosis?
    Marie M. Plante, MD, BSN, RN, Emily B. Wolf, MD and Razvan M. Chirila, MD
    Cleveland Clinic Journal of Medicine February 2024, 91 (2) 86-88; DOI: https://doi.org/10.3949/ccjm.91a.23045

    The authors review the current evidence on venous thromboembolic event (VTE) risk prediction in patients with cirrhosis, as well as VTE prophylaxis and anticoagulant therapy.

  • In Reply: Surgical and procedural management of benign prostatic hyperplasia
    Ayodeji E. Sotimehin, MD and Bradley C. Gill, MD, MS
    Cleveland Clinic Journal of Medicine February 2024, 91 (2) 83-84; DOI: https://doi.org/10.3949/ccjm.91c.02004
  • Surgical and procedural management of benign prostatic hyperplasia
    Sameer Gadani, MD, Ihab Haddadin, MD, Justin Guan, MD, Michael Bergen, MD and Abraham Levitin, MD
    Cleveland Clinic Journal of Medicine February 2024, 91 (2) 83; DOI: https://doi.org/10.3949/ccjm.91c.02003
  • Management of venous thromboembolism in patients with active cancer
    Heloni M. Dave, MBBS and Alok A. Khorana, MD, FACP, FASCO
    Cleveland Clinic Journal of Medicine February 2024, 91 (2) 109-117; DOI: https://doi.org/10.3949/ccjm.91a.23017

    The authors review the presentation and diagnosis of venous thromboembolism in patients with cancer and present an approach to treatment that aims to balance the bleeding risk from anticoagulation with the risk of recurrent thrombosis.

  • von Willebrand disease: A guide for the internist
    Varinder Kaur, MD, Omar Elghawy, MD, Saarang Deshpande, MD and David Riley, MD
    Cleveland Clinic Journal of Medicine February 2024, 91 (2) 119-127; DOI: https://doi.org/10.3949/ccjm.91a.22033

    The pathophysiology of von Willebrand disease, its subtypes, common presentations of each subtype, diagnostic testing, and management of clinical manifestations of the disease are reviewed.

  • Diagnosis and management of pancreatic cystic lesions for the non-gastroenterologist
    Diagnosis and management of pancreatic cystic lesions for the non-gastroenterologist
    Arjun Chatterjee, MD, Tyler Stevens, MD, FACG, FASGE and Prabhleen Chahal, MD, FACG, FASGE
    Cleveland Clinic Journal of Medicine February 2024, 91 (2) 96-102; DOI: https://doi.org/10.3949/ccjm.91a.23019

    A summary of current guidelines from several organizations on the diagnosis and surveillance of pancreatic cystic lesions.

  • Hypertension and severe hyperreninemia in a young man
    Joshua M. Leisring, MD, Jason Lyou, MD, Eshetu Obole, MD and Amy A. Yau, MD
    Cleveland Clinic Journal of Medicine February 2024, 91 (2) 103-108; DOI: https://doi.org/10.3949/ccjm.91a.23055

    A 29-year-old man with blood pressure measurements of 152/118 mm Hg and 156/116 mm Hg at 2 separate clinic visits is started on combination antihypertensive therapy and undergoes evaluation for secondary causes of hypertension.

Pages